Global Anti-Inflammatory Therapeutics Market Report 2026: Emerging Trends and Growth Scenarios
Uncover key drivers, emerging technologies, and competitive movements shaping the anti-inflammatory therapeutics market from 2026–2035 with trusted insights from The Business Research Company
By how much is the Anti-Inflammatory Therapeutics Market expected to grow between 2026 and 2030?
The anti-inflammatory therapeutics market has experienced consistent growth in its size during recent years. It is projected to expand from $117.28 billion in 2025 to $122.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.3%. This historical expansion can be ascribed to several factors, including the increasing prevalence of arthritis, a rise in inflammatory bowel disease cases, the growth in hospital pharmacy networks, the adoption of corticosteroids, and the sustained demand for pain management drugs.
The anti-inflammatory therapeutics market size is projected to experience significant growth in the coming years. This market is set to expand to $152.04 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.6%. The expansion during the forecast period is attributable to the advancement of targeted biologics, the integration of AI in drug discovery, the growth of online pharmacies, an increasing geriatric population, and a rising focus on personalized medicine. Prominent trends throughout this period encompass personalized anti-inflammatory therapies, an elevated use of biologic drugs, minimally invasive drug delivery systems, a surge in chronic pain management, and the widening distribution through online pharmacies.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp
Which Drivers Are Influencing Market Acceleration In The Anti-Inflammatory Therapeutics Market?
The rising occurrence of inflammatory bowel disease is projected to fuel the expansion of the anti-inflammatory therapeutics market. Inflammatory bowel disease (IBD) is a persistent condition marked by inflammation in the gastrointestinal tract. Anti-inflammatory therapeutics are essential in treating Crohn’s disease, as they work to reduce inflammation, manage symptoms, and decrease the need for surgery. For instance, in June 2023, Crohn’s and Colitis Canada, a Canada-based non-profit, reported that the number of inflammatory bowel disease (IBD) sufferers in Canada is expected to reach 470,000 by 2035, an increase from an estimated 322,600 in 2023. This escalating prevalence of inflammatory bowel disease is thus a primary driver for the anti-inflammatory therapeutics market’s growth.
What Segments Are Identified Within The Structure Of The Anti-Inflammatory Therapeutics Market?
The anti-inflammatory therapeutics market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics
2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen
2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone
3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins
What Trends Are Driving The Growth Trajectory Of The Anti-Inflammatory Therapeutics Market?
Key companies operating within the anti-inflammatory therapeutics market are concentrating on developing advanced biologic therapies to enhance treatment outcomes for individuals suffering from chronic inflammatory conditions. These sophisticated treatments are designed to deliver targeted immune modulation, improved effectiveness, and better tolerability compared to traditional remedies like corticosteroids. For instance, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, and Sanofi, a France-based pharmaceutical and healthcare company, launched Kevzara (sarilumab), which is the first and only anti-inflammatory biologic recommended for adult patients with polymyalgia rheumatica (PMR) who do not respond adequately to corticosteroids or are unable to tolerate corticosteroid tapering. This novel IL-6 receptor inhibitor offers a more potent and steroid-sparing therapeutic choice, addressing a significant unmet need in PMR management and reinforcing the companies’ presence in the anti-inflammatory therapeutics market.
Which Major Firms Are Strengthening Their Position In The Anti-Inflammatory Therapeutics Market?
Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Co. Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.
Access The Complete Report For Deeper Market Insights:
Which Region Shows The Strongest Potential For Future Expansion In The Anti-Inflammatory Therapeutics Market?
North America was the largest region in the anti-inflammatory therapeutics market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Anti-Inflammatory Therapeutics Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp
Browse Through More Reports Similar to the Global Anti-Inflammatory Therapeutics Market 2026, By The Business Research Company
Anti Inflammatory Therapeutics Market Report 2026
Non Steroidal Anti Inflammatory Drugs Market Report 2026
Rare Inflammatory Disease Treatment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
